Trial intelligence / Profile preview

Nal-P-113 mouthwash and oral bacteria / periodontal index

ChiCTR-OIC-16010250Phase 3Completed

Sponsor
School and Hospital of Stomatology, China Medical University
Start
Oct 2012
Modality
Antimicrobial Peptides → Native Peptides → Peptides
Countries
1
01

Overview

Phase 3 trial of Nal-P-113 in gingival disease (2 arms), sponsored by School and Hospital of Stomatology, China Medical University. Primary endpoints: Plaque index, Plaque area and 4 more. Started Oct 2012; status: completed.

02

Drugs

Nal-P-113
03

Conditions

gingival disease

Beyond the preview

Go deeper on ChiCTR-OIC-16010250.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-OIC-16010250.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call